Qrativ Company
Qrativ is a developer of a drug purposing platform designed to reinvent the way treatments for diseases with unmet medical.
Total Funding:
8300000.0
Headquarters:
Cambridge, Massachusetts, United States
Funding Status:
Early Stage Venture
Employee Number:
11-50
Estimated Revenue:
$1M to $10M
Last Funding Type:
Series A
Technology:
['BioTech & HealthTech']
Last Funding Date:
2017-07-14
Investors Number:
3.0
Founded Date:
2017-01-01
Industry:
Medical BioTech